Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

The IL-23/Th17 axis in the immunopathogenesis of psoriasis.

Di Cesare A, Di Meglio P, Nestle FO.

J Invest Dermatol. 2009 Jun;129(6):1339-50. doi: 10.1038/jid.2009.59. Epub 2009 Mar 26. Review.

2.

Critical role of the interleukin-23/T-helper 17 cell axis in the pathogenesis of psoriasis.

Nakajima K.

J Dermatol. 2012 Mar;39(3):219-24. doi: 10.1111/j.1346-8138.2011.01458.x. Review.

PMID:
22352845
3.

Inflammatory skin disease in K5.hTGF-beta1 transgenic mice is not dependent on the IL-23/Th17 inflammatory pathway.

Fitch EL, Rizzo HL, Kurtz SE, Wegmann KW, Gao W, Benson JM, Hinrichs DJ, Blauvelt A.

J Invest Dermatol. 2009 Oct;129(10):2443-50. doi: 10.1038/jid.2009.88. Epub 2009 Apr 9.

4.

Role of IL-23 in the pathogenesis of psoriasis: a novel potential therapeutic target?

Chiricozzi A, Saraceno R, Chimenti MS, Guttman-Yassky E, Krueger JG.

Expert Opin Ther Targets. 2014 May;18(5):513-25. doi: 10.1517/14728222.2014.889686. Epub 2014 Feb 25. Review.

PMID:
24568095
5.

Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines.

Fitch E, Harper E, Skorcheva I, Kurtz SE, Blauvelt A.

Curr Rheumatol Rep. 2007 Dec;9(6):461-7. Review.

6.

Immunopathogenesis and role of T cells in psoriasis.

Ghoreschi K, Weigert C, Röcken M.

Clin Dermatol. 2007 Nov-Dec;25(6):574-80. Review.

PMID:
18021895
7.

Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model.

Nakajima K, Kanda T, Takaishi M, Shiga T, Miyoshi K, Nakajima H, Kamijima R, Tarutani M, Benson JM, Elloso MM, Gutshall LL, Naso MF, Iwakura Y, DiGiovanni J, Sano S.

J Immunol. 2011 Apr 1;186(7):4481-9. doi: 10.4049/jimmunol.1000148. Epub 2011 Feb 23. Erratum in: J Immunol. 2011 Dec 1;187(11):6157-8.

8.

T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis.

Blauvelt A.

J Invest Dermatol. 2008 May;128(5):1064-7. doi: 10.1038/jid.2008.85. Review.

9.

From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited.

Boniface K, Blom B, Liu YJ, de Waal Malefyt R.

Immunol Rev. 2008 Dec;226:132-46. doi: 10.1111/j.1600-065X.2008.00714.x. Review.

10.

Psoriasis and other Th17-mediated skin diseases.

Tokura Y, Mori T, Hino R.

J UOEH. 2010 Dec 1;32(4):317-28. Review.

PMID:
21226422
11.

Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.

van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP, Lubberts E.

J Immunol. 2009 May 1;182(9):5836-45. doi: 10.4049/jimmunol.0802999.

12.

The roles of cells and cytokines in the pathogenesis of psoriasis.

Coimbra S, Figueiredo A, Castro E, Rocha-Pereira P, Santos-Silva A.

Int J Dermatol. 2012 Apr;51(4):389-95; quiz 395-8. doi: 10.1111/j.1365-4632.2011.05154.x. Review.

PMID:
22435425
13.

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.

Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, Ouyang W.

Nature. 2007 Feb 8;445(7128):648-51. Epub 2006 Dec 24.

PMID:
17187052
14.

IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.

Ortega C, Fernández-A S, Carrillo JM, Romero P, Molina IJ, Moreno JC, Santamaría M.

J Leukoc Biol. 2009 Aug;86(2):435-43. doi: 10.1189/JLB.0109046.

15.

Targeting the development and effector functions of TH17 cells.

Ghilardi N, Ouyang W.

Semin Immunol. 2007 Dec;19(6):383-93. Epub 2008 Jan 14. Review.

PMID:
18083530
16.

IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells.

Nograles KE, Zaba LC, Shemer A, Fuentes-Duculan J, Cardinale I, Kikuchi T, Ramon M, Bergman R, Krueger JG, Guttman-Yassky E.

J Allergy Clin Immunol. 2009 Jun;123(6):1244-52.e2. doi: 10.1016/j.jaci.2009.03.041. Epub 2009 May 12.

17.

The link between IL-23 and Th17 cell-mediated immune pathologies.

McGeachy MJ, Cua DJ.

Semin Immunol. 2007 Dec;19(6):372-6. doi: 10.1016/j.smim.2007.10.012. Epub 2007 Dec 3. Review.

PMID:
18319054
18.

Ustekinumab in psoriasis immunopathology with emphasis on the Th17-IL23 axis: a primer.

Quatresooz P, Hermanns-Lê T, Piérard GE, Humbert P, Delvenne P, Piérard-Franchimont C.

J Biomed Biotechnol. 2012;2012:147413. doi: 10.1155/2012/147413. Epub 2012 Jun 12. Review.

19.

Interleukin-23 in the pathogenesis and treatment of psoriasis.

Kollipara R, Downing C, Gordon R, Tyring S.

Skin Therapy Lett. 2015 Mar-Apr;20(2):1-4. Review.

20.

Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.

Shen W, Durum SK.

Neurochem Res. 2010 Jun;35(6):940-6. doi: 10.1007/s11064-009-0091-9. Epub 2009 Nov 14. Review.

PMID:
19915978
Items per page

Supplemental Content

Write to the Help Desk